News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

December 2014

Top

Merck acquires Swiss oncology drug development company OncoEthix
22 December 2014 US-based drugmaker Merck has acquired Swiss biotechnology company specialised in oncology drug development,...

AstraZeneca’s Lynparza obtains European approval for BRCA-mutated ovarian cancer
22 December 2014 British-Swedish drugmaker AstraZeneca has obtained approval from the European Commission (EC) for its twice-daily Lynparza (olaparib) capsules...

Halozyme and Janssen to develop and commercialise subcutaneous products
19 December 2014 US-based Halozyme Therapeutics has signed a worldwide collaboration and licence agreement with Janssen Biotech to develop and commercialise subcutaneous products by using Enhanze...

NICE recommends Boehringer Ingelheim's Pradaxa to treat fatal blood clots in adults
19 December 2014 The UK's National Institute for Health and Care Excellence (NICE) has recommended the anti-blood clotting drug dabigatran, Boehringer Ingelheim's Pradaxa, to treat fatal blood clots in the...

GlobalData reveals major pharmaceutical firms spent $112bn on R&D in 2013
18 December 2014 Approximately 30 major pharmaceutical firms worldwide have spent a combined $112bn on R&D in 2013, an increase of $723m compared to the previous year, according to research and consulting...

GSK forms new European consortium to advance Ebola vaccine candidate
18 December 2014 British drugmaker GlaxoSmithKline (GSK) and three leading research institutions has formed a new European consortium to help further advance development of a candidate vaccine against...

Ranbaxy to introduce malarial treatment Synriam in African nations
17 December 2014 Ranbaxy Laboratories has obtained regulatory approval to introduce India's first new chemical entity (NCE) Synriam (arterolane maleate 150mg and piperaquine phosphate 750mg drug) in seven...

Novartis receives FDA approval for Signifor LAR to treat acromegaly
17 December 2014 Swiss drugmaker Novartis has received approval from US Food and Drug Administration (FDA) for its Signifor long-acting release LAR (pasireotide) for injectable suspension and intramuscular use...

Nanotherapeutics to acquire Baxter’s Vero cell vaccines platform
16 December 2014 Baxter International has signed an agreement with Nanotherapeutics to sell its Vero cell technology and related...

Pfizer and OPKO collaborate to develop and commercialise hGH-CTP to treat GHD
16 December 2014 US-based drug maker Pfizer has signed a worldwide agreement with OPKO Health to develop and commercialise hGH-CTP to treat growth hormone deficiency (GHD) in adults and...

Sanofi receives FDA approval for Fluzone Intradermal Quadrivalent vaccine to treat influenza
15 December 2014 Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Fluzone Intradermal Quadrivalent...

Janssen and USAID collaborate to expand access to MDR-TB compound
15 December 2014 Johnson & Johnson associate Janssen Therapeutics has signed a memorandum of understanding (MoU) with US Agency for International Development (USAID) to expand access to...

New Zealand approves Mylan-Abbott $5bn deal
12 December 2014 New Zealand's competition watchdog Commerce Commission has approved Mylan's purchase of Abbott Laboratories's generic medicines arm Established...

UK reserves ready for Sierra Leone deployment to fight against Ebola
12 December 2014 The UK reserves and approximately 100 regulars are set to be deployed to Sierra Leone to help fight the Ebola...

Germany bans 80 generic drugs trialled at GVK Biosciences facility in India
11 December 2014 Germany has banned 80 generic drugs whose clinical trials undertaken by GVK Biosciences in India were found to be...

Bayer to support DNDi on oral drug development for river blindness
11 December 2014 Bayer HealthCare has agreed to provide the ingredient emodepside to support Drugs for Neglected Diseases initiative (DNDi) in its effort to develop a new oral drug to treat river blindness,...

SMC recommends GSK’s Incruse Ellipta to treat COPD within NHS Scotland
10 December 2014 The Scottish Medicines Consortium (SMC) has recommended GlaxoSmithKline's (GSK) Incruse Ellipta 55mcg (umeclidinium) to treat patients with chronic obstructive pulmonary (COPD) within NHS...

Outcomes Based Healthcare secures £1m grant to transform diabetes care
10 December 2014 UK-based Outcomes Based Healthcare has secured a £1m match-funded grant from Innovate UK, to lead the drive towards a more personalised, data-driven approach to improving health outcomes...

Pfizer establishes gene therapy unit for rare disease research
09 December 2014 US-based drugmaker Pfizer has established a gene therapy platform to investigate potential treatments for...

India’s Aurobindo acquires nutritional US supplement maker Natrol for $132.5m
09 December 2014 India-based Aurobindo Pharma has completed the acquisition of US-based nutritional supplement maker Natrol for...

November’s top stories: Actavis buys Allergan, antibiotics misunderstood in UK
08 December 2014 Ireland-based pharmaceutical company Actavis signed an agreement to acquire US-based Botox-maker Allergan for $66bn or $219 per...